Implications of Human Antimicrobial Peptide Defensin Beta-1 in Clinical Oral Squamous Cell Carcinoma Patients via an Integrated Bioinformatics Approach.
Simin LiHu LiYuzhen XuWanchen NingShaonan HuShanzun WeiHongning SongJianghe SunDirk ZiebolzGerhard SchmalzXianda HuMin LiuPublished in: Computational and mathematical methods in medicine (2022)
Given the dysregulation, prognostic value, and tumor progression-related biological pathway alteration, indicating the tumor immune-modulatory role of DEFB1 in OSCC, the DEFB1 gene should be regarded as a potential therapeutic target for treating oral cancer.